A Short History of the Mast Cell

Reference

• Alm P. E., Bloom G. D., Henriksson R. Anomalous effects of disodium cromoglycate. Int Archs Allergy Appl Immun 1981; 66: 416–426
   PubMedGoogle Scholar
• Austen K. F., Wasserman S. I., Goetzl E. J. Mast cell-derived mediators: struaural and functional diversity and regulation of expression. Molecular and Biological Aspects of the Acute Allergic Reactions, S. G. O. Johansson, K. Strandberg, B. Uvnäs. Plenum Press, New York 1976; 293–318
   Google Scholar
• Benditt E. P., Wong R., Arase M., Roeper E. 5-Hydroxytryptamine in mast cells. Proc Soc Exptl Biol Med (N. Y.) 1955; 90: 303–304
   PubMed Web of Science ®Google Scholar
• Benditt E. P., Arase M. An enzyme in mast cells with properties like chymotrypsin. J Exptl Med 1959; 110: 451–460
   PubMedGoogle Scholar
• Bloom G. D. Structural and biochemical characteristics of mast cells. The Inflammatory Process, B. W. Zweifach, L. Grant, R. T. McCluskey. Academic Press, Inc, 1974; 545–599
   Google Scholar
• Boreus L. O., Chakravarty N. Tissue mast cells, histamine and “slow reacing substance” in anaphylactic reaction in guinea pig. Acta Physiol Scand 1959; 48: 315–322
   Google Scholar
• Demopoulos C. A., Pinkard R. N., Hanahan D. J. Platelet-activating factor—Evidence for I-0-alkyl-2-acetyl-sn-glyceryl-3 - phosphorocholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979; 254: 9355–9358
   PubMed Web of Science ®Google Scholar
• Ehrlich P. Beiträge zur Kenntnis der granulierten Bindegewebszellen und der eosinophilen Leukocythen. Arch Anat Physiol 1879; 3: 166–169
   Google Scholar
• Enerbäck L. Studies on mast cells. 5-hydroxytryptamine content of mast cells in carcinoid tumours and some properties of gastrointestinal mast cells in the rat. Diss. Med., Univ. of Gothenburg, Gothenburg, Sweden 1966
   Google Scholar
• Fawcett D. W. An experimental study of mast cell degranulation and regeneration. Anat Rec 1955; 121: 29–42
   PubMedGoogle Scholar
• Feldberg W., Kellaway C. H. Liberation of histamine and formation of lysocithin-like substances by cobra venon. J Physiol 1938; 94: 187–226
   PubMedGoogle Scholar
• Ginsburg H., Sachs L. Formation of pure suspensions of mast cells in tissue culture by differention of lymphoid cells from mouse thymus. J Natl Cancer Inst 1963; 31: 1–39
   PubMedGoogle Scholar
• Ginsburg H., Nir I., Hammel I., Weissman R., Eren B.-A., Naot Y. Differentiation and activity of mast cells following immunization in cultures of lymph-node cells. Immunology 1978; 35: 485–502
   PubMed Web of Science ®Google Scholar
• Holmgren H., Wilander O. Beitrag zur Kenntnis der Chemie und Funktion der Ehrlichschen Mastzellen. 2 Mikr-anat Forsch 1937; 42: 242–278
   Google Scholar
• Ishizaka K., Ishizaka T. Mechanisms of reaginic hypersensitivity: a review. Clinical Allergy 1971; 1: 9–24
   PubMedGoogle Scholar
• Jorpes E. On heparin: Its chemical nature and properties. Acta Med Scund 1936; 88: 427433
   Google Scholar
• Jorpes E., Holmgren H., Wilander O. Über das Vorkommen von Heparin in den Gefäss-wänden und in den Augen. Z Mikr-anat Forsch 1937; 42: 279–301
   Google Scholar
• Kaliner M., Wasserman S. I., Austen K. F. Immunologic release of chemical mediators from human nasal polyps. New Engl J Med 1973; 289: 277–81
   PubMed Web of Science ®Google Scholar
• Kay A. B., Stechschulte D. J., Austen K. F. An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med 1971; 133: 602–619
   PubMed Web of Science ®Google Scholar
• Kellaway C. H., Trethewie E. R. The liberation of slow-reacting smooth musclestimulating substance in anaphylaxis. Quart J Exp Physiol 1940; 30: 121–145
   Google Scholar
• Lagunoff D., Benditt E. Proteolytic enzymes of mast cells. Ann NY Acad Sci 1963; 103: 185–197
   PubMedGoogle Scholar
• Levy D. A., Frondoza C. Immunity to intestinal parasites: role of mast cells and goblet cells. Fed Proc 1983; 42: 1750–1755
   PubMedGoogle Scholar
• Lichtenstein L. M., Foreman J. C., Conroy M. C., Marone G., Newball H. H. Differences between histamine release from rat mast cells and human basophils and mast cells. The Mast Cell: Its Role in Health and Disease, J. Pepys, A. M. Edards. Pitman Medical Publishing Co., KentEngland 1979; 83
   Google Scholar
• Lison L. Etudes sur la métachromasie. Colorants métachromatiques et substances chromo-tropes. Arch de Biol (Paris) 1935; 46: 599–668
   Google Scholar
• MacIntosh F. C., Paton W. D. M. The liberation of histamine by certain organic bases. J Physiol (Lond) 1949; 109: 191–217
   Google Scholar
• Maximow A. Über die Zellformen des lockeren Bindegewebes. Arch Mikr Anat (Bonn) 1906; 67: 680–757
   Google Scholar
• Metcalfe D. D., Lewis R. A., Silbert J. E., Rosenberg R. D., Wasserman S. I., Austen K. F. Isolation and characterization of heparin from human lung. J Clin Invest 1979; 64: 1537–1543
   PubMed Web of Science ®Google Scholar
• Michels N. A. The mast cells. Handbook of Hematology, Downey. P. B. Hoeber Inc., New York 1938; vol. 1: 232, Reprinted: Ann NY Acad Sci 103 235–372 (1963)
   Google Scholar
• Mongar J. L., Perera B. A. V. The role of the chymotrypsin-like enzyme in rat mast cells in anaphylaxis. Biochem Pharmacol 1963; 12: 213, suppl.
   PubMedGoogle Scholar
• Orange R. P., Austen K. F. Slow reacting substance of anaphylaxis. Adv Immunol 1969; 10: 105–144
   PubMedGoogle Scholar
• Orange R. P., Stechshulte D. J., Austen K. F. Cellular mechanisms involved in the release of slow reacting substance of anaphylaxis. Fed Proc 1969; 28: 1710–1715
   PubMedGoogle Scholar
• Parrat J. R., West G. B. 5-Hydroxytryptamine and tissue mast cells. J Physiol (Lond) 1957; 137: 169–178
   Google Scholar
• Paton W. D. M. Compound 48/80: a potent histamine liberator. Brit J Pharmacol 1951; 6: 499–508
   Web of Science ®Google Scholar
• von Recklinghausen F. Über Eiter- und Bindegewebskörperchen. Virchows Arch Path Anat 1863; 28: 157
   Google Scholar
• Riley J. F. The effects of histamine liberators on the mast cells of the rat. J Path Bact 1953; 65: 471–479
   PubMedGoogle Scholar
• Riley J. F., West G. B. Mast cells and histamine in normal and pathological tissues. J Physiol (Lond) 1953; 119: 44
   Google Scholar
• Ruitenberg E. J., Elgersma A. Absence of intestinal mast cell response in congenitally athymic mice during Trichinella spiralis infection. Nature 1976; 264: 258–260
   PubMedGoogle Scholar
• Samuelsson B., Borgeat P., Hammarström S., Murphy R. C. Introduction of a nomenclature: Leukotrienes. Prostaglandins 1980; 17: 785–787
   Google Scholar
• Schwartz L. B., Lewis R. A., Austen K. F. Tryptase from human pulmonary mast cells: purification and characterization. J Biol Chem 1981; 256: 11939–11943
   PubMed Web of Science ®Google Scholar
• Selye H. The Mast Cells. Butterworths, Washington 1965
   Google Scholar
• Siraganian R. P., Osler A. G. Destruction of rabbit platelets in the allergic response of sensitized leukocytes. II. Evidence of basophil involvement. J Immunol 1971; 106: 1252–1259
   PubMedGoogle Scholar
• Uvnäs B., Thon I. L. Isolation of “biologically intact” mast cells. Exp Cell Res 1959; 18: 512–520
   PubMedGoogle Scholar
• Uvnäs B., Thon I. L. Evidence for enzymatic histamine release from isolated rat mast cells. Exp Cell Res 1961; 23: 45–57
   PubMedGoogle Scholar
• Wasserman S. I., Goetzl E. J., Austen K. F. Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). J Immunol 1974; 112: 351–358
   PubMed Web of Science ®Google Scholar
• Yoo D., Lessin L. S., Jensen W. Bone marrow mast cells in lymphoproliferative disorders. The Mast Cell—Its Role in Health and Disease, J. Pepys, A. M. Edwards. Pitman Medical, New York 1979; 153–156
   Google Scholar